CCT
TEVA icon

Country Club Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Country Club Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-48,820
Closed -$859K – 225
2017
Q3 		$859K Sell
48,820
-114,167
-70% -$2.57M 0.12% 112
2017
Q2 		$5.41M Sell
162,987
-1,852
-1% -$57.3K 0.79% 48
2017
Q1 		$5.29M Buy
164,839
+8,870
+6% +$303K 0.73% 52
2016
Q4 		$5.65M Sell
155,969
-14,459
-8% -$577K 0.89% 43
2016
Q3 		$7.84M Buy
170,428
+17,974
+12% +$938K 1.11% 28
2016
Q2 		$7.66M Buy
152,454
+19,143
+14% +$1.02M 1.11% 27
2016
Q1 		$7.13M Buy
133,311
+28,365
+27% +$1.66M 1.07% 29
2015
Q4 		$6.89M Buy
104,946
+400
+0.4% +$24.7K 1.05% 28
2015
Q3 		$5.9M Sell
104,546
-1,510
-1% -$97.9K 0.91% 40
2015
Q2 		$6.27M Sell
106,056
-34,810
-25% -$2.15M 0.89% 39
2015
Q1 		$8.78M Sell
140,866
-4,185
-3% -$243K 1.24% 23
2014
Q4 		$8.34M Sell
145,051
-17,693
-11% -$986K 1.1% 26
2014
Q3 		$8.75M Buy
162,744
+22,890
+16% +$1.21M 1.17% 20
2014
Q2 		$7.33M Sell
139,854
-1,048
-0.7% -$53.6K 0.96% 32
2014
Q1 		$7.45M Buy
140,902
+10,089
+8% +$466K 1.05% 28
2013
Q4 		$5.24M Sell
130,813
-5,790
-4% -$228K 0.77% 57
2013
Q3 		$5.16M Buy
136,603
+7,708
+6% +$301K 0.82% 48
2013
Q2 		$5.05M Buy
+128,895
New +$5.02M 0.85% 37

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Country Club Trust's TEVA Position: Q4 2017 in Review

Country Club Trust sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 48,820 shares — an estimated $859K sold.

Country Club Trust first reported a position in TEVA in Q2 2013 and held it in 18 quarters. The position peaked at $8.78M in Q1 2015. 507 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • Country Club Trust reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Country Club Trust sold 48,820 Teva Pharmaceuticals shares in Q4 2017, an estimated $859K.
  • Country Club Trust first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Country Club Trust's Teva Pharmaceuticals position peaked at $8.78M in Q1 2015.
  • 507 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on Country Club Trust's 13F filing for Q4 2017, filed 12 Jan 2018.